GLOBAL NEWS MEDICAL

Aprecia partners with Battelle to accelerate 3D Printed Pharmaceutical Manufacturing

3D printed pharmaceutical
3D printed pharmaceutical
Above: 3D printed pharmaceutical manufacturing/Image Source: Aprecia

Aprecia, the 3D printed pharmaceutical company, announced this week that it has established a long-term partnership with Battelle, a global research and development organization, to accelerate and expand its advanced capabilities in 3D Printed pharmaceutical manufacturing. The collaboration will be focused on advancing 3DP equipment from clinical supply through commercial scale, while increasing manufacturing throughput and efficiency at every level.

Battelle’s innovative design teams will focus on expanding the capabilities of Aprecia’s 3DP technology platform addressing important pharmaceutical product challenges through 3DP innovation

Above: Aprecia’s proprietary 3DP manufacturing process, ZipDose® Technology/Video Source: Aprecia

Speaking about the partnership, Aprecia CEO, Chris Gilmore said, “Aprecia’s internal equipment design team and its current technology partners have established its global leadership in 3DP commercial scale manufacturing. The Aprecia leadership team is highly optimistic about combining its years of 3DP experience with the innovation and engineering talents of Battelle. We believe this partnership will have long-term impact on Aprecia’s ability to solve medication design challenges that will offer significant benefits to patients across multiple therapeutic categories.” 

According to Sanj Pai, Vice President and General Manager of Battelle’s Health business, “Additive manufacturing (3DP) is expanding rapidly and across many industries. Aprecia has invested the time and resources necessary to become the leader in 3D printed pharmaceutical manufacturing. We envision great opportunities in leveraging Aprecia equipment platforms and intellectual property to best serve the pharmaceutical industry.”

About Aprecia: Founded in 2003, Aprecia received the first and only FDA approved three-dimensionally-printed (3DP) pharmaceutical product approval in 2015 and is the global leader in utilizing 3DP technology for commercial-scale, pharmaceutical manufacturing. Aprecia’s proprietary 3DP technology includes a multi-patented, binder-jetting, manufacturing system, allowing for both Open-Bed and In-Cavity printing, as well as their advanced formulation and rapid-prototyping platforms. 

About Battelle: Battelle is a global research and development organization committed to science and technology for the greater good. Headquartered in Columbus, Ohio since its founding in 1929, Battelle makes the world better by commercializing technology, giving back to our communities, and supporting science, technology, engineering and mathematics (STEM) education.


About Manufactur3D Magazine: Manufactur3D is an online magazine on 3D Printing. Visit our Global News page for more updates on Global 3D Printing News. To stay up-to-date about the latest happenings in the 3D printing world, like us on Facebook or follow us on LinkedIn.

Related posts

Markforged & Carahsoft Partner-up to Offer Rapid Production of Metal and Carbon Fiber parts to Government Agencies

MANUFACTUR3D

Protolabs Joins MIT’s Centre for Additive and Digital Advanced Production Technologies (ADAPT) as its Founding Member

MANUFACTUR3D

Swinburne University’s Repairbot 3D Prints Replacement Bracket onto Automotive Part

MANUFACTUR3D